Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging

Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis

(2013) D.R. Altmann et al.   Multiple Sclerosis and Related Disorders

Automatic Lesion Incidence Estimation and Detection in Multiple Sclerosis Using Multisequence Longitudinal MRI

(2012) E.M. Sweeney et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Oligodendrocytes and the early multiple sclerosis lesion

(2012) John W. Prineas et al.   ANNALS OF NEUROLOGY

Neuroplasticity and functional recovery in multiple sclerosis

(2012) Valentina Tomassini et al.   Nature Reviews Neurology

Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis

(2012) Robert A. Brown et al.   NEUROIMAGE

Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions

(2011) María I. Gaitán et al.   ANNALS OF NEUROLOGY

Is the magnetization transfer ratio a marker for myelin in multiple sclerosis?

(2011) Irene M. Vavasour et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Population-wide principal component-based quantification of blood–brain-barrier dynamics in multiple sclerosis

(2011) Russell T. Shinohara et al.   NEUROIMAGE

Review: The architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis

(2011) H. Lassmann   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials

(2010) Andrew P. D. Henderson et al.   BRAIN

Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis

(2010) IJ van den Elskamp et al.   Multiple Sclerosis Journal

Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions

(2009) Andrew P. D. Henderson et al.   ANNALS OF NEUROLOGY

Sample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosis

(2009) B Healy et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI

(2009) K. Schmierer et al.   NEUROLOGY

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

(2008) L. K. Fisniku et al.   BRAIN

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis

(2008) IJ van den Elskamp et al.   Multiple Sclerosis Journal

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

(2008) D. R. Altmann et al.   NEUROLOGY